| Company Name: | ICON plc ADS | | Ticker Symbol: | ICLR | | | WWW Address: | www.iconclinical.com | | CEO: | Peter Gray | | No. of Employees: | 6,975 | | Common Issue Type: | AD | | Business Description: | The Company is a contract research organization, providing outsourced development services on a global basis to the pharmaceutical, biotechnology and medical device industries.
|
| | | Industry Information: | DIVERSIFIED SERVICES - Research Services [more like this] |
|
| Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 23.39 |  -0.06 | 22.72 | 23.74 | 23.6 | 23.65 | 23.05 | 216750 |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 1,370.7 | 58.6 | 0.72 | 1.30 | 0.00 | 16.4 | 0.0 | 26.85 - 12.17 |
|
| KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 23.39 | $ | | PE Ratio - LTM | 16.4 | |
| Market Capitalisation | 1,370.6 | mil |
| Latest Shares Outstanding | 58.6 | mil |
| Earnings pS (EPS) | 1.30 | $ |
| Dividend pS (DPS) | 0.00 | ¢ |
| Dividend Yield | 0.0 | % |
| Dividend Payout Ratio | 0 | % |
| Revenue per Employee | 124,050 | $ |
| Effective Tax Rate | 20.3 | % |
| Float | 0.0 | mil |
| Float as % of Shares Outstanding | 0.0 | % |
| Foreign Sales | 706 | mil |
| Domestic Sales | 159 | mil |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 20.30 | % |
| Research & Devlopment (R&D) as % of Revenue | 0.00 | % |
| Gross Profit Margin | 56.6 | % |
| EBITDA Margin | 36.3 | % |
| Pre-Tax Profit Margin | 8.8 | % |
| Assets Turnover | 1.3 | % |
| Return on Assets (ROA) | 9.2 | % |
| Return on Equity (ROE) | 15.6 | % |
| Return on Capital Invested (ROCI) | 14.9 | % |
| Current Ratio | 1.7 | |
| Leverage Ratio (Assets/Equity) | 1.7 | |
| Interest Cover | 26.0 | |
| Total Debt/Equity (Gearing Ratio) | 0.05 | |
| LT Debt/Total Capital | 5.0 | % |
| Working Capital pS | 3.68 | $ |
| Cash pS | 1.16 | $ |
| Book-Value pS | 9.22 | $ |
| Tangible Book-Value pS | 6.06 | $ |
| Cash Flow pS | 1.96 | $ |
| Free Cash Flow pS | 1.54 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 2.54 | |
| Price/Tangible Book Ratio | 3.86 | |
| Price/Cash Flow | 12.0 | |
| Price/Free Cash Flow | 15.2 | |
| P/E as % of Industry Group | 36.0 | % |
| P/E as % of Sector Segment | 8.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | - |
| Dividend Rate | 0.00 |
| Current Dividend Yield | 0.0 |
| 5-Y Average Dividend Yield | 0.0 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 0.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | |
| |
| PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 1.7 | 100 | 2,831 | 7,668 |
| 4 Weeks | 25.24 | 22.15 | 24.70 | -5.3 | 88 | 2,655 | 47,797 |
| 13 Weeks | 26.85 | 21.30 | 21.72 | 7.7 | 100 | 3,846 | 238,477 |
| 26 Weeks | 26.85 | 17.25 | 17.44 | 34.1 | 111 | 3,714 | 467,928 |
| 52 Weeks | 26.85 | 12.17 | 21.19 | 10.4 | 89 | 4,928 | 1,231,935 |
| YTD | 26.85 | 12.17 | - | 18.8 | 97 | 4,903 | 1,117,865 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 23.08 | 22.91 | 23.79 | 21.92 | 20.90 | 0.72 | 0.62 |
|
| |
| GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | 33.88 | 80.5 | 35.90 |
| Income | 50.93 | 69.7 | 35.72 |
| Dividend | 0.00 | 0.0 | 0.00 |
| Capital Spending | 46.18 | NA | 104.90 |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 40.31 | NA | 35.73 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 45.2 | 40.6 | 37.2 |
| Earnings % | 11.1 | 12.0 | 39.6 |
| EPS % | 14.0 | 14.3 | 38.3 |
| EPS $ | 0.13 | 0.05 | 0.36 |
|
| |
| SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| Net Working Capital Ratio | 21.44 |
| Current Ratio | 1.6 |
| Quick Ratio (Acid Test) | 1.0 |
| Liquidity Ratio (Cash) | 0.32 |
| Receivables Turnover | 4.7 |
| Average Collection Period | 77 |
| Working Capital/Equity | 40.7 |
| Working Capital pS | 3.18 |
| Cash-Flow pS | 1.81 |
| Free Cash-Flow pS | -0.61 |
| FINANCIAL STRUCTURE RATIOS |
| Altman's Z-Score Ratio | 3.77 |
| Financial Leverage Ratio (Assets/Equity) | 1.9 |
| Debt Ratio | 47.4 |
| Total Debt/Equity (Gearing Ratio) | 0.23 |
| LT Debt/Equity | 0.14 |
| LT Debt/Capital Invested | 18.5 |
| LT Debt/Total Liabilities | 16.0 |
| Interest Cover | 24.9 |
| Interest/Capital Invested | 0.74 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 9.96 |
| Tobin's Q Ratio | 1.58 |
| Current P/E Ratio - LTM | 16.40 |
| Enterprise Value (EV)/EBITDA | 13.22 |
| Enterprise Value (EV)/Free Cash Flow | -59.98 |
| Dividend Yield | 0.0 |
| Price/Tangible Book Ratio - LTM | 3.86 |
| Price/Book Ratio - LTM | 2.54 |
| Price/Cash Flow Ratio | 12.0 |
| Price/Free Cash Flow Ratio - LTM | 15.2 |
| Price/Sales Ratio | 1.19 |
| P/E Ratio (1 month ago) - LTM | 18.3 |
| P/E Ratio (26 weeks ago) - LTM | 10.3 |
| P/E Ratio (52 weeks ago) - LTM | 13.9 |
| 5-Y High P/E Ratio | 97.1 |
| 5-Y Low P/E Ratio | 12.0 |
| 5-Y Average P/E Ratio | 37.4 |
| Current P/E Ratio as % of 5-Y Average P/E | 44 |
| P/E as % of Industry Group | 36.0 |
| P/E as % of Sector Segment | 8.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 16.4 |
| PER SHARE FIGURES |
| LT Debt pS | 1.12 |
| Current Liabilities pS | 5.37 |
| Tangible Book Value pS - LTM | 6.06 |
| Book Value pS - LTM | 9.22 |
| Capital Invested pS | 8.90 |
| Cash pS - LTM | 1.16 |
| Cash Flow pS - LTM | 1.96 |
| Free Cash Flow pS - LTM | 1.54 |
| Earnings pS (EPS) | 1.30 |
| | | | OPERATING RATIOS | | PROFITABILITY RATIOS |
| Free Cash Flow Margin | -4.11 |
| Free Cash Flow Margin 5YEAR AVG | -2.82 |
| Net Profit Margin | 9.0 |
| Net Profit Margin - 5YEAR AVRG. | 7.8 |
| Equity Productivity | 1.90 |
| Return on Equity (ROE) | 17.1 |
| Return on Equity (ROE) - 5YEAR AVRG. | 11.9 |
| Capital Invested Productivity | 1.66 |
| Return on Capital Invested (ROCI) | 15.0 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | 11.1 |
| Assets Productivity | 1.10 |
| Return on Assets (ROA) | 9.0 |
| Return on Assets (ROA) - 5YEAR AVRG. | 7.1 |
| Gross Profit Margin | 56.6 |
| Gross Profit Margin - 5YEAR AVRG. | 43.8 |
| EBITDA Margin - LTM | 36.3 |
| EBIT Margin - LTM | 9.1 |
| Pre-Tax Profit Margin | 11.4 |
| Pre-Tax Profit Margin - 5YEAR AVRG. | 10.2 |
| Effective Tax Rate | 20.3 |
| Effective Tax Rate - 5YEAR AVRG. | 27.9 |
| EFFICIENCY RATIOS |
| Cash Conversion Cycle | 95 |
| Revenue per Employee | 124,050 |
| Net Income per Employee | 11,200 |
| Average Collection Period | 95 |
| Receivables Turnover | 4.7 |
| Day's Inventory Turnover Ratio | 0 |
| Inventory Turnover | 0.0 |
| Inventory/Sales | 0.0 |
| Accounts Payble/Sales | 18.70 |
| Assets/Revenue | 0.91 |
| Net Working Capital Turnover | 4.65 |
| Fixed Assets Turnover | 2.36 |
| Total Assets Turnover | 1.1 |
| Revenue per $ Cash | 14.82 |
| Revenue per $ Plant | 5.04 |
| Revenue per $ Common Equity | 1.90 |
| Revenue per $ Capital Invested | 1.66 |
| Selling, General & Adm/tive (SG&A) as % of Revenue | 28.8 |
| SG&A Expense as % of Revenue - 5YEAR AVRG. | 30.1 |
| Research & Devlopment (R&D) as % of Revenue | 0.0 |
| R&D Expense as % of Revenue - 5YEAR AVRG. | 0.0 |
|
|  
|
| |
 |  |